Guided Therapeutics EBITDA margin
What is the EBITDA margin of Guided Therapeutics?
The EBITDA margin of Guided Therapeutics, Inc. is -3,861.64%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on OTC compared to Guided Therapeutics
What does Guided Therapeutics do?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Companies with ebitda margin similar to Guided Therapeutics
- Mt Malcolm Mines NL has EBITDA margin of -3,946.88%
- Virgin Galactic Inc has EBITDA margin of -3,939.68%
- Ragnar Metals has EBITDA margin of -3,891.41%
- Acacia Pharma Plc has EBITDA margin of -3,872.66%
- Middle Island Resources has EBITDA margin of -3,868.53%
- Vivani Medical Inc has EBITDA margin of -3,865.54%
- Guided Therapeutics has EBITDA margin of -3,861.64%
- Montello Resources has EBITDA margin of -3,858.40%
- Magnis Technologies has EBITDA margin of -3,810.36%
- Perisson Petroleum has EBITDA margin of -3,800.95%
- Duesenberg Technologies has EBITDA margin of -3,786.68%
- Revance Therapeutics Inc has EBITDA margin of -3,773.65%
- Bulletin Resources has EBITDA margin of -3,769.57%